Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 2
2018 1
2020 1
2021 2
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Cancer risk in patients with sleep apnoea following adherent 5-year CPAP therapy.
Justeau G, Bailly S, Gervès-Pinquié C, Trzepizur W, Meslier N, Goupil F, Pigeanne T, Launois S, Leclair-Visonneau L, Masson P, Bizieux-Thaminy A, Racineux JL, Gozal D, Gagnadoux F; ERMES Study Group. Justeau G, et al. Eur Respir J. 2022 Apr 7;59(4):2101935. doi: 10.1183/13993003.01935-2021. Print 2022 Apr. Eur Respir J. 2022. PMID: 34475228 Free article.
Hypoxic burden and heart rate variability predict stroke incidence in sleep apnoea.
Blanchard M, Gervès-Pinquié C, Feuilloy M, Le Vaillant M, Trzepizur W, Meslier N, Goupil F, Pigeanne T, Balusson F, Oger E, Sabil A, Girault JM, Gagnadoux F; ERMES study group. Blanchard M, et al. Eur Respir J. 2021 Mar 25;57(3):2004022. doi: 10.1183/13993003.04022-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 33214210 Free article. No abstract available.
Association Between Nocturnal Hypoxemia and Cancer Incidence in Patients Investigated for OSA: Data From a Large Multicenter French Cohort.
Justeau G, Gervès-Pinquié C, Le Vaillant M, Trzepizur W, Meslier N, Goupil F, Pigeanne T, Launois S, Leclair-Visonneau L, Masson P, Bizieux-Thaminy A, Humeau MP, Gosselin C, Blanchard M, Urban T, Gagnadoux F; ERMES Study Group. Justeau G, et al. Chest. 2020 Dec;158(6):2610-2620. doi: 10.1016/j.chest.2020.06.055. Epub 2020 Jul 3. Chest. 2020. PMID: 32629036
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC.
Pinto C, Normanno N, Orlandi A, Fenizia F, Damato A, Maiello E, Tamburini E, Di Costanzo F, Tonini G, Bilancia D, Corsi D, Pisconti S, Ferrau F, Gori S, Daniele B, Zaniboni A, Soto Parra H, Frassinetti GL, Iaffaioli RV, Cassata A, Zampino MG, Repetto L, Calegari MA, Barone C; all the investigators of ERMES study group.. Pinto C, et al. Future Oncol. 2018 Jun;14(14):1339-1346. doi: 10.2217/fon-2017-0592. Epub 2018 May 30. Future Oncol. 2018. PMID: 29846100 Clinical Trial.
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis.
Trentini A, Manfrinato MC, Castellazzi M, Tamborino C, Roversi G, Volta CA, Baldi E, Tola MR, Granieri E, Dallocchio F, Bellini T, Fainardi E; Emilia-Romagna network for Multiple Sclerosis (ERMES) study group. Trentini A, et al. Mult Scler. 2015 Aug;21(9):1121-30. doi: 10.1177/1352458514560925. Epub 2015 Feb 6. Mult Scler. 2015. PMID: 25662349
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis.
Rizzo R, Pietrobon S, Mazzoni E, Bortolotti D, Martini F, Castellazzi M, Casetta I, Fainardi E, Di Luca D, Granieri E, Tognon M; Emilia-Romagna network for Multiple Sclerosis (ERMES) study group. Rizzo R, et al. J Transl Med. 2016 Jul 22;14(1):216. doi: 10.1186/s12967-016-0981-y. J Transl Med. 2016. PMID: 27443345 Free PMC article.